Cite

HARVARD Citation

    Hasegawa, J. et al. (2016). Novel anti-EPHA2 antibody, DS-8895a for cancer treatment. Cancer biology & therapy. 17 (11), pp. 1158-1167. [Online]. 
  
Back to record